Veterinary Laboratory Investigation and Response Network Renate Reimschuessel 1, Sarah Nemser 1, Andriy Tkachenko 1, Olgica Ceric 1, Jake Guag 1, David.

Slides:



Advertisements
Similar presentations
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Advertisements

Thailand National Focal Point for IFCS Chemical Safety Section Food and Drug Administration Ministry of Public Health July 2003.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
Food Safe Schools: what‘s it all about? Presentation Objectives  Participants will gain an understanding of the importance of food safety throughout.
1 Christopher Melluso Elizabeth Higgins FDA/CVM State of New Mexico Pet Event Tracking Network (PETNet)
DR. CHRISTINA RUNDI MINISTRY OF HEALTH, MALAYSIA.
Food Emergency Response Network (FERN) FDA Science Board Advisory Committee Meeting November 6, 2003 Carl J. Sciacchitano Office of Regulatory Affairs/Division.
Enhancing Capacity for Surveillance of Healthy Living & Chronic Disease in Canada Paula Stewart MD, FRCPC Public Health Agency of Canada APHEO, September.
Becker Grand Rounds: Wally Pellerite June 30, 2011.
Collaboration Workshop for Global Health System Strengthening Triangle Global Health Consortium 02 December 2009 Sally S. Tinkle Senior Science Advisor,
Produce Safety Rule Phase 2 Workgroup 1.
Vernon D. Toelle, Ph.D. Team Leader Pre-Market Compliance and Administrative Actions Team (BIMO Team) Overview of CVM Bioresearch Monitoring.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
It’s More than Giving Shots to Puppies & Kittens! The Secrets of Veterinary Medicine.
HOMELAND SECURITY and AMERICAN COUNCIL OF INDEPENDENT LABORATORIES An Environmental Sciences Section Perspective Robert Wyeth Severn Trent Laboratories.
World Organisation for Animal Health (OIE) Creation of the Office International des Epizooties (OIE) World Organisation for Animal Health (OIE) Creation.
Protecting and Promoting Your Health How this work supports FDA’s mission: TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic.
DSaRM Advisory Committee May 18, 2005 Active Surveillance for Drug Safety Signals: Past, Present, and Future Mary Willy, Ph.D. Division of Drug Risk Evaluation.
Predicting human dose-response relationships from multiple biological models: Issues with Cryptosporidium parvum Risk Assessment Consortium.
Laboratory Twinning – a tool to improve global disease security Keith Hamilton.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
Food Supply Defense Plan: Lessons from Oregon Public Health
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Physiologists & the FDA Kevin J. Greenlees, Ph.D., DABT Senior Advisor for Science & Policy Office of New Animal Drug Evaluation FDA Center for Veterinary.
The International Food Standards and Recommendations Prof. Elisaveta Stikova M.D., Ph.D. School of Medicine University “St. Cyril and Methodius” – Skopje.
CVM: Protecting human and animal health 2011 Update Renate Reimschuessel CVM/Office of Research.
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control June 14, 2011 : The Food Safety Modernization Act: Implications.
Enhancing International Capacity to Meet SPS Standards Mo Salman Animal Population Health Institute College of Veterinary Medicine and Biomedical Sciences.
C-059-I0 EVET C-061-I0 DVEFVMPVLM A-041-N0 B-004-H0 AORTA D-115-G0 C-068-I0 UP- DMHTE.
United States Department of Agriculture Food Safety and Inspection Service FSIS Foodborne Illness Investigations: Current Thinking Scott A. Seys, MPH Chief,
FDA Science Board Drug Safety Initiative April 15, 2005 Rockville, MD RADM Steven Galson, MD, MPH Acting Director, Center for Drug Evaluation and Research.
TASK FORCE ON WRDs SURVEILLANCE TASK FORCE ON WRDs SURVEILLANCE Monica Francesca Blasi, Paola Meli, Mario Carere, Enzo Funari National Institute of Health.
Counter-terrorism at FDA Andrea Meyerhoff MD Director, Office of Counter-terrorism US Food and Drug Administration.
“History is a set of lies agreed upon.” Napoleon Bonaparte.
Global Foodborne Infections Network (GFN) Building capacity to detect, control and prevent foodborne and other enteric infections from farm to table National.
1 OIE CAPACITY BUILDING ACTIVITIES Regional Information Seminar for Recently Appointed OIE Delegates 18 – 20 February 2014, Brussels, Belgium Dr Mara Gonzalez.
National Presentation Template Workshop: The State of National Governance Relative to the International Health Regulations (2005) Ottawa, Canada,
Food Defense 2005 CDC Public Health Preparedness Conference February 24th, 2005 David W. K. Acheson M.D. Director, Office of Food Safety, Defense and Outreach.
Dr. David Mowat June 22, 2005 Federal, Provincial & Local Roles Surveillance of Risk Factors and Determinants of Chronic Diseases.
Food Safety …From Farm to Table By: Allison Weis
Major Components of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation.
1 U.S. Food and Drug Administration International Programs Melinda K. Plaisier Assistant Commissioner for International Programs U.S. Food and Drug Administration.
HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
James N. Chestnut Chief, Scientific Support Branch November 20, 2015 Office of Acquisitions & Grants Services (OAGS) SMART PROC 2015.
Nanotechnology - USDA - 18 Nov 2002 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D.
Meeting to Strengthen the Capacity of Chemical Risk Assessment in LAC PAHO, December th, 2013 PAHO’s ANTECEDENTS ON TDS & INFORMATION ON LABORATORY.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
One Health meeting Day one summary report Rapporteurs Cameroon and Uganda 12 Nov 2012.
National Institutes of Health U.S. Department of Health and Human Services Planning for a Team Science Evaluation ∞ NIEHS: Children’s Health Exposure Analysis.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
October 4, 2004 Building Steps for Canada’s New Integrated Enteric Pathogen Surveillance Program 12th Annual APHEO Conference October 4, 2004 Niagara Falls,
Veterinary Pharmacovigilance Discussion
Center for Veterinary Medicine Strategic Planning, 2002
HUMAN RESEARCH PROTECTION PROGRAM or
World Organisation for Animal Health (OIE)
“The SOCIETY shall cooperate with scientists internationally and shall be concerned with the worldwide application of chemistry to the needs of humanity.”
Ontario Association of Bovine Practitioners November 6, 2003
Food Supply Defense Plan: Lessons from Oregon Public Health
World Organisation for Animal Health
The role of the OIE in biological threat reduction
The Role of NICs in Influenza Surveillance
Response Teams – Planning and Preparation
Twinning workshop, Cairo
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Increasing Preparedness Capacities across the Mediterranean - IPCAM 2 Luigi D’Angelo Italian Civil Protection Department Brussels, 18 January 2017.
Care of Research Animals
Presentation transcript:

Veterinary Laboratory Investigation and Response Network Renate Reimschuessel 1, Sarah Nemser 1, Andriy Tkachenko 1, Olgica Ceric 1, Jake Guag 1, David Rotstein 2 1 United States Food and Drug Administration, Center for Veterinary Medicine, Office of Research, 8401 Muirkirk Rd, Laurel, MD USA 2 United States Food and Drug Administration, Center for Veterinary Medicine, Office of Surveillance and Compliance, 7519 Standish Place, Rockville, MD 20708, USA Map depicts geographic location of Vet-LIRN laboratories based on the Food Emergency Response Network (FERN) Regions Diagnostic Response The Veterinary Laboratory Investigation and Response Network (Vet-LIRN) coordinates with the FDA Office of Surveillance and Compliance (S&C) to evaluate potential adverse event cases involving CVM regulated products. In turn, Vet-LIRN coordinates the resources and expertise of various veterinary diagnostic laboratories to further investigate select cases through diagnostic testing and analysis. Funding There are a total of 37 network laboratories 30 receive infrastructure grant funding 11 receive method grant funding Proficiency Testing Collaborating with the CFSAN’s Division of Food Processing Science and Technology and the Institute for Foods Safety and Health, Illinois Institute of Technology Vet-LIRN offered 13 Proficiency Tests:  Salmonella in dog fecal samples (4 PT rounds)  Listeria in dog food samples (2 PT rounds)  Aflatoxin in milk (2 PT rounds)  Flunixin in milk  Copper in ruminant liver  Lead in equine blood  Melamine and Cyanuric Acid in fish muscle  Melamine and Cyanuric Acid histopathology Vet-LIRN MISSION TO PROMOTE HUMAN and ANIMAL HEALTH by collaborating with veterinary diagnostic laboratories in order to - provide scientific information - build laboratory capacity for routine and emergency response - train scientists TO INVESTIGATE POTENTIAL PROBLEMS with CVM regulated products - animal foods and animal drugs Cooperative Agreement Program: Evaluation of Salmonella in Symptomatic and Asymptomatic Pets Eleven Vet-LRN cooperative agreement laboratories are evaluating Salmonella prevalence in the cat and dog pet population across the country. Goals for the study include: Harmonize and validate methods Establish future surveillance needs Identify a baseline for comparative analysis Collaborations with other Networks Vet-LIRN became a member of the Integrated Consortium of Laboratory Networks (ICLN) in This membership will help increase connectivity and collaboration with other laboratory networks accountable for providing timely, credible, and interpretable data in support of surveillance, early detection, and consequence management of events requiring an integrated national laboratory response. Publications Nemser et al. Investigation of Listeria, Salmonella, and Toxigenic Escherichia coli in Various Pet Foods. Foodborne Pathogens and Disease Tkachenko et al. Investigation of melamine and cyanuric acid deposition in pig tisssues using LC-MS/MS methods.Food and Chemical Toxicology How this work supports FDA’s mission :  Contributes to overall food and drug safety as animal food and drug events may signal potential issues in the human food and drug system.  Supports efforts to develop and evaluate diagnostic methods to facilitate testing conducted by network laboratories when investigating adverse events.  Facilitates collaborations with other stakeholders and timely exchange of information that can be crucial for identifying a problem with FDA regulated products. This project was supported in part by an appointment to the Research Participation Program at the Center for Veterinary Medicine administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S.DOE and the U.S.FDA.